Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Clinical Pharmacology

Radiotherapy in periocular cutaneous malignancies: A retrospective study

Dermatology | Apr 05, 2019 Clinical Pharmacology

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF^V600E or BRAF^V600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): A randomised, placebo-controlled, phase 3 trial

The Lancet Oncology | Apr 02, 2019 Clinical Pharmacology

Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: Integrated results from phase 3, randomized, placebo-controlled, PIONEER trials

British Journal of Dermatology | Mar 31, 2019 Clinical Pharmacology

Rituximab therapy in patients with bullous pemphigoid: A retrospective study of 20 patients

Journal of the American Academy of Dermatology | Mar 29, 2019 Clinical Pharmacology

A potential link between desmoglein 3 and epidermal growth factor receptor in oral squamous cell carcinoma and its effect on cetuximab treatment efficacy

Experimental Dermatology | Mar 29, 2019 Clinical Pharmacology

Phototherapy-induced elevation of serum level of melanoma inhibitory activity

Photodermatology, Photoimmunology and Photomedicine | Mar 29, 2019 Clinical Pharmacology

Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis

Journal of the American Academy of Dermatology | Mar 28, 2019 Clinical Pharmacology

Prevalence estimates for pemphigus in the united states: A sex- and age-adjusted population analysis

JAMA | Mar 27, 2019 Clinical Pharmacology

C-reactive protein (CRP) rs3093059C predicts poor mizolastine response in chronic spontaneous urticaria patients with elevated serum CRP level

Experimental Dermatology | Mar 23, 2019 Clinical Pharmacology

Risk factors for increased serum creatinine level in patients with psoriasis treated with cyclosporine in a real-world practice

Dermatologic Therapy | Mar 23, 2019 Clinical Pharmacology

« Prev 1 … 57 58 59 60 61 … 92 Next »

Radiotherapy in periocular cutaneous malignancies: A retrospective study

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF^V600E or BRAF^V600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): A randomised, placebo-controlled, phase 3 trial

Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: Integrated results from phase 3, randomized, placebo-controlled, PIONEER trials

Rituximab therapy in patients with bullous pemphigoid: A retrospective study of 20 patients

A potential link between desmoglein 3 and epidermal growth factor receptor in oral squamous cell carcinoma and its effect on cetuximab treatment efficacy

Phototherapy-induced elevation of serum level of melanoma inhibitory activity

Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis

Prevalence estimates for pemphigus in the united states: A sex- and age-adjusted population analysis

C-reactive protein (CRP) rs3093059C predicts poor mizolastine response in chronic spontaneous urticaria patients with elevated serum CRP level

Risk factors for increased serum creatinine level in patients with psoriasis treated with cyclosporine in a real-world practice

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Minimally Invasive Dentistry

Leptin Hormone: Its Role in Food Intake & Energy Expenditure

More Women Experience Chronic Pain Than Men: Find Out Why

Radiotherapy in periocular cutaneous malignancies: A retrospective study

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): A randomised, placebo-controlled, phase 3 trial

Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: Integrated results from phase 3, randomized, placebo-controlled, PIONEER trials

Rituximab therapy in patients with bullous pemphigoid: A retrospective study of 20 patients

A potential link between desmoglein 3 and epidermal growth factor receptor in oral squamous cell carcinoma and its effect on cetuximab treatment efficacy

Phototherapy-induced elevation of serum level of melanoma inhibitory activity

Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis

Prevalence estimates for pemphigus in the united states: A sex- and age-adjusted population analysis

C-reactive protein (CRP) rs3093059C predicts poor mizolastine response in chronic spontaneous urticaria patients with elevated serum CRP level

Risk factors for increased serum creatinine level in patients with psoriasis treated with cyclosporine in a real-world practice

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Minimally Invasive Dentistry

Leptin Hormone: Its Role in Food Intake & Energy Expenditure

More Women Experience Chronic Pain Than Men: Find Out Why

Select Specialty

Select Topic

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF^V600E or BRAF^V600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): A randomised, placebo-controlled, phase 3 trial